The principal business address for each of the Reporting Persons is 2 Overhill Road, Scarsdale, NY 10583.

Iroquois Capital Management LLC is a Delaware limited liability company. Richard Abbe is an individual who is a citizen of the United States of America. Kimberly Page is an individual who is a citizen of the United States of America.

Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of shares of securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference. The Reporting Persons' ownership of the Issuer's securities includes: (i) 875,000 shares of Common Stock held directly by IMF and 1,625,000 shares of Common Stock held directly by ICIG, (ii) pre-funded warrants held directly by IMF that are exercisable for an aggregate of up to 5,833,333 shares of Common Stock and pre-funded warrants held directly by ICIG that are exercisable for an aggregate of up to 10,833,333 shares of Common Stock (collectively, the "Pre-Funded Warrants"), all of which are subject to a 9.99% Beneficial Ownership Blocker (as defined below); (iv) warrants held directly by IMF that are exercisable for an aggregate of up to 20,341,760 shares of Common Stock and warrants held directly by ICIG that are exercisable for an aggregate of up to 17,698,882 shares of Common Stock (collectively, the "Base Warrants", and together with the "Pre-Funded Warrants", the "Warrants"), all of which are subject to a 4.99% Beneficial Ownership Blocker (as defined below); and (v) 692,554 shares of Common Stock issuable upon conversion of shares of Preferred Stock held directly by IMF and 157,951 shares of Common Stock issuable upon conversion of shares of Preferred Stock held directly by ICIG (collectively, the "Preferred Shares"), all of which are subject to a 4.99% Beneficial Ownership Blocker. The Pre-Funded Warrants contain provisions which precludes the exercise of such Pre-Funded Warrants to the extent that, following exercise, the holder, together with its affiliates and other attribution parties, would own more than 9.99% of the Common Stock outstanding (the "9.99% Beneficial Ownership Blocker"). The Base Warrants and Preferred Shares contain provisions which precludes the exercise of such Base Warrants or the conversion of such Preferred Shares to the extent that, following exercise or conversion, as applicable, the holder, together with its affiliates and other attribution parties, would own more than 4.99% of the Common Stock outstanding (the "4.99% Beneficial Ownership Blocker", and together with the 9.99% Beneficial Ownership Blocker, the "Beneficial Ownership Blockers"). The Reporting Persons are currently prohibited from exercising the Warrants or converting the Preferred Stock to the extent that such exercise or conversion, as applicable, would result in beneficial ownership of more than 2,527,084 shares of Common Stock. The shares of Common Stock listed as beneficially owned in Rows 6, 8 and 9 of the cover page for each Reporting Person and the percentage set forth in Row 11 of the cover page for each Reporting Person give effect to the Beneficial Ownership Blockers. Consequently, as of the date of the event which requires the filing of this statement, the Reporting Persons were not able to exercise all of the Warrants or convert the Preferred Shares due to the Beneficial Ownership Blockers.

Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of the date of the event which requires filing of this statement and is incorporated herein by reference. Due to the Beneficial Ownership Blockers, the collective beneficial ownership percentage of the Reporting Persons was 9.99% as of the date of the event which requires filing of this statement. Such percentage is based upon the sum of (i) 11,319,039 shares of the Issuer's Common Stock outstanding as of February 17, 2025, as reported in the Issuer's final prospectus dated February 17, 2025, filed with the Securities and Exchange Commission ("SEC") pursuant to Rule 424(b)(4) on February 19, 2025 (the "Final Prospectus"), (ii) 13,950,012 shares of Common Stock contemplated to be issued in the Issuer's public offering as described in the Final Prospectus, and (iii) 27,084 shares of Common Stock issuable upon the exercise of the Warrants and/or conversion of the Preferred Shares, after giving effect to the Beneficial Ownership Blockers.

The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.

The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.